azacitidine has been researched along with Gangliocytoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allemanni, G; Banelli, B; Bonassi, S; Borzì, L; Brigati, C; Casciano, I; Di Vinci, A; Mazzocco, K; Romani, M; Scaruffi, P; Tonini, GP | 1 |
Clark, GJ; Ekström, TJ; Farnebo, F; Geli, J; Juhlin, C; Kiss, N; Kogner, P; Lanner, F; Larsson, C; Natalishvili, N | 1 |
2 other study(ies) available for azacitidine and Gangliocytoma
Article | Year |
---|---|
Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.
Topics: 14-3-3 Proteins; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Child; Child, Preschool; Cohort Studies; CpG Islands; DNA Methylation; DNA, Neoplasm; Exonucleases; Exoribonucleases; Female; Ganglioneuroblastoma; Ganglioneuroma; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Proteins; Neuroblastoma; Prognosis; Proportional Hazards Models; Risk; Risk Assessment; Sequence Analysis, DNA; Soft Tissue Neoplasms; Survivors | 2010 |
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bromodeoxyuridine; Cell Line, Tumor; DNA Methylation; Down-Regulation; Ganglioneuroma; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydroxamic Acids; Monomeric GTP-Binding Proteins; Neuroblastoma; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |